Drug profile · INN
dabigatran
ARX-DABIGATRAN
dabigatran (ARX-DABIGATRAN) is a thrombin inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 1
Pipeline programs 13
News articles 0
Drug details — dabigatran
- Class
- —
- Route
- —
- Patents
- 1
- Programs
- 13
- Data quality
- 0.81
Quick answer
dabigatran (ARX-DABIGATRAN) is a thrombin inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN dabigatran
Brand ARX-DABIGATRAN
Mechanism Thrombin inhibitor
Target Prothrombin
Originator Alphapharm Pty Ltd
Mechanism of action
Thrombin inhibitor
Primary target: Prothrombin
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is dabigatran?
dabigatran (ARX-DABIGATRAN) is a thrombin inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for dabigatran?
ARX-DABIGATRAN is a marketed brand name for dabigatran. Check FDA Drugs@FDA for the current US label holder and prescribing information.